$HTSC The Company holds a 15% equity stake in KRTL Biotech. KRTL Biotech has MFDS approval to study psilocybin in South Korea with its highly ambitious team of doctors, chemists and researchers to help cure debilitating diseases.
https://www.heretoserve.tech/